Shinyu Izumi - Concepedia

Author

Shinyu Izumi

National Center for Global Health and Medicine ORCID

Also Known As

Despoina Papakosta, Izumi Shinyu, Izumi, Shinyu, S IZUMI, S Izumi, S. IZUMI, S. Izumi, S., Izumi, Sara Izumi, Shibuya Izumi

189

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

National Center for Global Health and Medicine Kanagawa Cardiovascular and Respiratory Center NHO Kinki Chuo Chest Medical Center Kobe City Medical Center General Hospital Tosei General Hospital

About

Shinyu Izumi is an author at National Center for Global Health and Medicine specializing in medicine, covid-19, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	984
2	Public Health	4	4	155
3	Social Sciences	1	1	27
4	Allergy	1	1	13
5	Cellular Physiology	1	1	27

Shinyu Izumi

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown, The Lancet Respiratory Medicine Inbuild TrialParallel-group TrialAdvanced Lung DiseasePulmonary FibrosisPulmonary Medicine	2020	522
Inhaled GM-CSF for Pulmonary Alveolar Proteinosis Ryushi Tazawa, Takahiro Ueda, Mitsuhiro Abe, New England Journal of Medicine	2019	155
Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19 Masaya Sugiyama, Noriko Kinoshita, Satoshi Ide, Gene Disease ProgressionSevere/critical DiseaseMedicineSerum Ccl17 LevelImmunology	2020	104
The Importance of Bacterial and Viral Infections Associated with Adult Asthma Exacerbations in Clinical Practice Motoyasu Iikura, Masayuki Hojo, Rikiya Koketsu, PLoS ONE	2015	103
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study Toby M. Maher, Susanne Stowasser, Yasuhiko Nishioka, The Lancet Respiratory Medicine FibrosisExtracellular Matrix TurnoverInflammatory Lung DiseaseLung InflammationIdiopathic Pulmonary Fibrosis	2019	96
Sensitivity and specificity of QuantiFERON-TB Gold Plus compared with QuantiFERON-TB Gold In-Tube and T-SPOT.TB on active tuberculosis in Japan Jin Takasaki, Toshie Manabe, Eriko Morino, Journal of Infection and Chemotherapy Quantiferon-tb Gold PlusPulmonary TuberculosisTuberculosis PreventionTuberculosisTuberculosis Diagnostics	2017	84
Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial Yasuhiro Kondoh, Arata Azuma, Yoshikazu Inoue, American Journal of Respiratory and Critical Care Medicine	2020	76
HLA-A11:01:01:01, HLA-C12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure Seik‐Soon Khor, Yosuke Omae, Nao Nishida, Frontiers in Immunology	2021	62
Reducing Occurrence and Severity of Pneumonia Due to Pandemic H1N1 2009 by Early Oseltamivir Administration: A Retrospective Study in Mexico Anjarath Lorena Higuera Iglesias, Koichiro Kudo, Toshie Manabe, PLoS ONE	2011	51
Analysis of systemic lupus erythematosus-related interstitial pneumonia: a retrospective multicentre study Noriyuki Enomoto, Ryoko Egashira, Kazuhiro Tabata, Scientific Reports	2019	46

Page 1